Status:

RECRUITING

Smart Boot Use to Measure Offloading Adherence

Lead Sponsor:

University of Southern California

Collaborating Sponsors:

Baylor College of Medicine

Conditions:

Diabetic Foot Ulcer

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to help people with diabetes who develop neuropathic diabetic foot ulcers (DFUs). These ulcers, or sores, if left untreated can increase the chance of amputation. Part of ...

Eligibility Criteria

Inclusion

  • Male or Female aged 18 or older
  • Diabetic Foot Ulcer requiring offloading
  • Able to provide written informed consent

Exclusion

  • Wound present for more than one year
  • HbA1c \> 12%
  • Ankle Brachial Index (ABI) of index limb is \<0.9 and/or they are being considered for revascularization within the course of the study
  • Ulcer involving bone or tendon
  • Ulcer not caused by diabetes
  • Unable or unwilling to attend prescribed clinic visits
  • Fully confined to a wheelchair

Key Trial Info

Start Date :

October 19 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

210 Patients enrolled

Trial Details

Trial ID

NCT04460573

Start Date

October 19 2021

End Date

December 31 2025

Last Update

October 8 2024

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Rancho Los Amigos National Rehabilitation Center

Downey, California, United States, 90242

2

Verdugo Hills Hospital of USC

Glendale, California, United States, 91208

3

Clemente Clinical Research

Los Angeles, California, United States, 90033

4

Keck Medical Center of USC

Los Angeles, California, United States, 90033